Quarterly Result7 Aug 2026, 07:02 pm
Omkar Speciality Chemicals Files Delayed Financials Post-CIRP Admission
AI Summary
Omkar Speciality Chemicals Limited has filed its unaudited financial statements for the quarters ending September 2022, December 2022, and audited financial statements for the years ended March 31, 2023, 2024, and 2025. The company was admitted into Corporate Insolvency Resolution Process (CIRP) by the NCLT, Mumbai Bench on December 5, 2022, which led to constraints preventing timely submission of previous quarterly reports. The board meeting held on August 7, 2026, approved these financial statements, which are now available on the company's website. The filings include standalone unaudited and audited financial results for the pending periods and independent auditor's reports.
Key Highlights
- Company filed delayed financial results for multiple periods.
- CIRP admission in Dec 2022 caused submission constraints.
- Board approved financial statements up to FY 2024-25.
- Financials include unaudited and audited results.
- Results cover periods up to March 31, 2025.
Price Impact
More from OMKARCHEM